Diagnostics and Therapeutic Potential of miR-205 and miR-34a in Ovarian Cancer Management: A miRNA-Target-Based Analysis

被引:2
作者
Kumar, Vivek [1 ]
Pandey, Archana [1 ]
Arora, Arisha [2 ]
Gautam, Priyanka [1 ]
Bisht, Deepa [1 ]
Gupta, Sameer [3 ]
Chaurasia, Amrita [4 ]
Sachan, Manisha [1 ]
机构
[1] Motilal Nehru Natl Inst Technol, Dept Biotechnol, Allahabad, Prayagraj, India
[2] Indian Inst Technol, Dept Biosci & Bioengn, Gauhati, Assam, India
[3] King George Med Univ, Dept Surg Oncol, Lucknow, India
[4] Motilal Nehru Med Coll Allahabad, Dept Gynaecol & Obstet, Allahabad, Prayagraj, India
关键词
microRNA; targeted therapy; ovarian cancer; diagnostic potential; expression biomarker; qRT-PCR; PROMOTES; TUMORIGENESIS; METHYLATION; CARCINOMA; CELLS; GENES;
D O I
10.1089/dna.2022.0487
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epithelial ovarian cancer (EOC) treatment strategies mainly focused on surgery combined with chemotherapy. Recent targeted therapy techniques emerge as milestone and could be used for management of ovarian cancer (OC) progression with more efficacy. The aim is to evaluate the therapeutic and diagnostic potential of microRNA (miRNA) in management of EOC using in silico and quantitative real-time PCR (qRT-PCR) expression analysis. We performed functional enrichment and miRNA-Target genes expression analysis in 48 EOC and 22 normal tissue samples using qRT-PCR and correlated with miRNA expression data in matched samples to evaluate the diagnostic and therapeutic potential of miRNA in OC management. In silico functional enrichment analysis revealed miRNA association with disease. Target genes of miRNAs participate in several biologically important pathways leading to cancer progression. Targets of miRNA-205 and miRNA-34a were significantly downregulated, and upregulated, respectively, in EOC. Moreover, significant negative correlation between relative expression of miRNA-205 and target genes (BCL2, ZEB1, E2F1, and TP53) was observed with r = -0.813; r = -0.755; r = -0.559; and r = -0.767, respectively. Similarly, miRNA-34a also showed higher negative correlation with target genes (MDM4, MAPK3, BRCA1, AREG) with r = -0.840; r = -0.870; r = -0.622; and r = -0.623, respectively. In addition, receiver operating characteristics analysis of combined miRNA panel, miRNA-205-Target gene panel, and miRNA-34a-Target gene panel exhibited higher diagnostics value with area under the curve (AUC) of 92.7 (p < 0.0001), 94.8 (p < 0.0001), and 98.3 (p < 0.0001), respectively. Negative Correlation between miRNA and target genes expression data in matched samples highlights therapeutic potential of miRNA in EOC management. Moreover, combined diagnostic potential of miRNA-target gene panel could predict risk of EOC with higher AUC, sensitivity, and specificity.
引用
收藏
页码:151 / 162
页数:12
相关论文
共 31 条
  • [1] Identification of an Enhancer That Increases miR-200b∼200a∼429 Gene Expression in Breast Cancer Cells
    Attema, Joanne L.
    Bert, Andrew G.
    Lim, Yat-Yuen
    Kolesnikoff, Natasha
    Lawrence, David M.
    Pillman, Katherine A.
    Smith, Eric
    Drew, Paul A.
    Khew-Goodall, Yeesim
    Shannon, Frances
    Goodall, Gregory J.
    [J]. PLOS ONE, 2013, 8 (09):
  • [2] Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
    Calin, GA
    Dumitru, CD
    Shimizu, M
    Bichi, R
    Zupo, S
    Noch, E
    Aldler, H
    Rattan, S
    Keating, M
    Rai, K
    Rassenti, L
    Kipps, T
    Negrini, M
    Bullrich, F
    Croce, CM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (24) : 15524 - 15529
  • [3] A feedback circuit of miR-34a/MDM4/p53 regulates apoptosis in chronic lymphocytic leukemia cells
    Cao, Lei
    Liu, Yun
    Lu, Jin-Bo
    Miao, Yi
    Du, Xin-Yi
    Wang, Rong
    Yang, Hui
    Xu, Wei
    Li, Jian-Yong
    Fan, Lei
    [J]. TRANSLATIONAL CANCER RESEARCH, 2020, 9 (10) : 6143 - 6153
  • [4] Change in Survival in Metastatic Breast Cancer with Treatment Advances: Meta-Analysis and Systematic Review
    Caswell-Jin, Jennifer L.
    Plevritis, Sylvia K.
    Tian, Lu
    Cadham, Christopher J.
    Xu, Cong
    Stout, Natasha K.
    Sledge, George W.
    Mandelblatt, Jeanne S.
    Kurian, Allison W.
    [J]. JNCI CANCER SPECTRUM, 2018, 2 (04)
  • [5] miR-205 regulates the proliferation and invasion of ovarian cancer cells via suppressing PTEN/SMAD4 expression
    Chu, Ping
    Liang, Aihua
    Jiang, Aili
    Zong, Lu
    [J]. ONCOLOGY LETTERS, 2018, 15 (05) : 7571 - 7578
  • [6] Analysis of microRNA-34a expression profile and rs2666433 variant in colorectal cancer: a pilot study
    Fawzy, Manal S.
    Ibrahiem, Afaf T.
    Abu Alsel, Baraah T.
    Alghamdi, Saleh A.
    Toraih, Eman A.
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [7] Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status
    Gadducci, Angiolo
    Guarneri, Valentina
    Peccatori, Fedro Alessandro
    Ronzino, Graziana
    Scandurra, Giuseppa
    Zamagni, Claudio
    Zola, Paolo
    Salutari, Vanda
    [J]. JOURNAL OF OVARIAN RESEARCH, 2019, 12 (1)
  • [8] Epigenetic silencing of miR-493 increases the resistance to cisplatin in lung cancer by targeting tongue cancer resistance-related protein 1(TCRP1)
    Gu, Yixue
    Zhang, Zhijie
    Yin, Jiang
    Ye, Jiahui
    Song, Yin
    Liu, Hao
    Xiong, Yan
    Lu, Minying
    Zheng, Guopei
    He, Zhimin
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2017, 36
  • [9] Holschneider CH, 2000, SEMIN SURG ONCOL, V19, P3, DOI 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO
  • [10] 2-S